CRDO
R500#5 today
TARGET+34%
$210.17
+7.90% today · +7.25% 1W
Oct 1 close or latest
PreviewWhy it's moving
Outperforming without a clear catalyst yet
- CRDO +7.90% on the last session vs SPY +0.18%: +7.7 pts of stock-specific move.
- 6 Reddit mentions in the past 24 hours, 65% positive over the week.
- 1 analyst action in the past 10 days (0 positive, 1 negative); latest: Mizuho maintained Outperform, lowered target $290 → $245.
- 7 insider or congressional trades in the past 30 days, including 2 insider sales not under a 10b5-1 plan.
- Market backdrop (Wed): Core PCE Price Index m/m 0.2% vs 0.3% expected (cooler); Final GDP q/q 2.2% vs 1.5% expected (stronger); S&P futures +0.18%, 10-year yield +0bp in the 30 minutes after.
Assembled from Wallsti's own signals. The news-reading agent will explain the move with timestamped sources, and say so when there is no clear catalyst.
Key facts
- Market cap
- —
- Held by institutions
- —
- Short interest
- —
- 52-week range
- —
- Analyst mean target
- $281.09
- Forward P/E
- —
Recent events
Insider ▼
Yat Tung Lam (Chief Operating Officer, Director) sold 100,000 shares ($20.6M) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingInsider ▼
Chi Fung Cheng (Chief Technology Officer, Director) sold 27,500 shares ($5.3M) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingInsider ▼
James Laufman (Chief Legal Officer, Secretary) sold 5,000 shares ($925.0K), not under a 10b5-1 plan unplanned · filingAnalyst ▼
Mizuho maintained Outperform, lowered target $290 → $245Insider ▼
Chi Fung Cheng (Chief Technology Officer, Director) sold 27,500 shares ($4.6M) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingInsider ▼
William Joseph Brennan (Pres & Chief Executive Officer, Director) sold 16,672 shares ($2.5M) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingInsider ▼
Chi Fung Cheng (Chief Technology Officer, Director) sold 27,500 shares ($4.5M) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingInsider ▼
Chi Fung Cheng (Chief Technology Officer, Director) sold 3,790 shares ($644.3K), not under a 10b5-1 plan unplanned · filingAnalyst ▼
B of A Securities maintained Buy, lowered target $340 → $275Analyst ▲
Rosenblatt maintained Neutral, raised target $215 → $235